Loading...
•
Dec 31, 2019
Chemours Q4 2019 Earnings Report
Chemours' Q4 2019 results reflected a challenging year with solid fourth-quarter performance.
Key Takeaways
Chemours reported Q4 2019 net sales of $1.4 billion and a net loss of $(317) million, or $(1.94) per diluted share. Adjusted net income was $92 million, or $0.56 per diluted share, and adjusted EBITDA was $227 million. The company finished the year strong with $304 million in free cash flow.
Net sales were $1.4 billion.
Net loss was $(317) million, with EPS of $(1.94).
Adjusted net income was $92 million, with adjusted EPS of $0.56.
Free cash flow was $304 million.
Chemours
Chemours
Forward Guidance
The company expects to deliver 2020 Adjusted EBITDA within a range of $1.05 to $1.25 billion, capital expenditures of approximately $400 million, and Free Cash Flow of greater than $350 million. The company expects to deliver Adjusted EPS of between $2.60 and $3.55 per share.
Positive Outlook
- Top line growth across all segments.
- Bottom line growth across all segments.
- Significant improvement in free cash flow.
Challenges Ahead
- Macroeconomic environment remains uncertain.